- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 92.89M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.02B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.18B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $4.17B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $4.45B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.31B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $20.58B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $20.39B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.91B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $7.68B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $29.24B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $28.94B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 100.6M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $278M |
| Capex | Q1 2025 · Mar 31, 2024 | $240M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $586M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $21.38 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $21.60 |
| Operating Income | Q1 2025 · Mar 31, 2024 | $3.29B |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.37B |